Cigna, Novartis strike outcomes-based Entresto deal

Cigna Corp. (NYSE:CI) said Monday that it struck an outcomes-based pricing deal with Novartis AG (NYSE:NVS; SIX:NOVN) for heart failure drug Entresto sacubitril/valsartan.

Cigna said the agreement ties financial terms to improvement in health based on a primary metric of reduction in the proportion of customers with heart failure hospitalizations. ...